Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Endobronchial Cryotherapy in the Management of Malignant Endobronchial Obstruction in Patients With Inoperable NSCLC: A Prospective Analysis of Clinical and Survival Outcomes

NCT04710459 is registered in ClinicalTrials.gov with Mohamed Abdel Bary Ahmed Ibrahim as lead sponsor.

NCT NCT04710459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04710459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Endobronchial Cryotherapy in the Management of Malignant Endobronchial Obstruction in Patients With Inoperable NSCLC: A Prospective Analysis of Clinical and Survival Outcomes
Lead sponsor
Mohamed Abdel Bary Ahmed Ibrahim
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2016
Completion date
May 31, 2019
Enrollment
60 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bronchogenic cancer, non small cell lung cancer, non-small cell carcinoma of lung, tnm stage 4